THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$263.69
0.23 (0.09%)
▲
5d:
+0.08%
30d:
-1.16%
90d:
+52.27%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: THC is fairly valued with market pricing in 2.4% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: THC is fairly valued with market pricing in 2.4% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.69
Based on -31.8% avg growth
INTRINSIC VALUE TODAY
$15.33
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $263.69, which is considered fair relative to its 30-day fair value range of $258.66 to $272.02. The stock's valuation (Forward PE: 12.5) is in line with its historical norms (11.7). At these levels, the market is pricing in 2.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, THC is in a strong uptrend. Immediate support is located at $253.51, while resistance sits at $273.57.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (15th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, THC is in a strong uptrend. Immediate support is located at $253.51, while resistance sits at $273.57.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (15th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$258.66 -
$272.02
Company Quality Score
61/100
(BUY)
Options IV Signal
15th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
74.6%
Protect Your Profits
Holding THC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 15th percentile)
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($285.10)
- NEUTRAL: Market pricing in 2.4% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$258.66 -
$272.02
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$16.56
(6.3%)
Support & Resistance Levels
Support Level
$253.51
Resistance Level
$273.58
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.51
Wall Street Target
$285.10
(+8.1%)
Revenue Growth (YoY)
6.8%
Earnings Growth (YoY)
213.4%
Profit Margin
10.3%
Valuation Premium vs History
+2.4% premium
PE vs Historical
12.5 vs 11.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.4%
(market-implied from PE analysis)
1-Year Target
$270.02
(+2%)
2-Year Target
$276.50
(+5%)
3-Year Target
$283.13
(+7%)
3-Yr Target (if PE normalizes)
(PE: 13→12)
PE COMPRESSION
$264.84
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: -67.5%)
$416.67
(+58%)
Base:
(SPY PE: 12.5, Growth: -67.5%)
$258.39
(-2%)
Bear:
(PE: 10.6, Growth: -67.5%)
$219.63
(-17%)
📈
Valuation based on Current Earnings
Trailing PE: 10.41 | Current EPS (TTM): $25.32
Bull Case
$241.30
(-9%)
Analyst growth -16.7%, PE expands to 11.5
Base Case
$219.36
(-17%)
Market implied -16.7%, PE stable at 10.4
Bear Case
$179.15
(-32%)
Severe decline -20.0%, PE contracts to 8.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 11, 2026 8:32 PM ET
Data refreshes hourly during market hours. Next update: 9:32 PM
Data refreshes hourly during market hours. Next update: 9:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$40 | 60 BUY |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
